Viewing Study NCT04853368


Ignite Creation Date: 2025-12-24 @ 5:58 PM
Ignite Modification Date: 2026-01-24 @ 6:59 PM
Study NCT ID: NCT04853368
Status: TERMINATED
Last Update Posted: 2024-07-16
First Post: 2021-04-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Evaluate Adverse Events and Change in Disease Activity With Oral Capsules of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 Combination Therapies in Adult Participants With Cystic Fibrosis
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cystic Fibrosis (CF) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cystic Fibrosis (CF) View
None Galicaftor View
None Navocaftor View
None ABBV-119 View
None ABBV-576 View